SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-031793
Filing Date
2019-08-13
Accepted
2019-08-13 16:10:35
Documents
3
Period of Report
2019-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K urov-8k_20190813.htm 8-K 37733
2 EX-99.1 urov-ex991_6.htm EX-99.1 168113
3 GRAPHIC gyqfycig25yp000001.jpg GRAPHIC 10310
  Complete submission text file 0001564590-19-031793.txt   221337
Mailing Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617
Business Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Filer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38667 | Film No.: 191020726
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1